WuHan RedBird Biotech Co,Ltd.

Various top quality steroids, semi-finished oils, SARMs, other pharmaceutical raw materials.

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsPeptide Steroid Hormones

Pharma Grade Peptide Injections Anti Aging CJC 1295 With DAC CAS 863288 34 0

Certification
China WuHan RedBird Biotech Co,Ltd. certification
China WuHan RedBird Biotech Co,Ltd. certification
Customer Reviews
Ok thanks. So far everything looks good will be in contact. Once again great business I appreciate it

—— Russell

ja natürlich ist die Qualität gut von euch.ich kaufe ja immer bei euch.

—— Joachim

Thanks my brother it is on the way.. Be here at my house Monday.. Yes .. Good morning to u.. And I'm working to do more soon..!

—— Terry

I'm Online Chat Now

Pharma Grade Peptide Injections Anti Aging CJC 1295 With DAC CAS 863288 34 0

Pharma Grade Peptide Injections Anti Aging CJC 1295 With DAC CAS 863288 34 0
Pharma Grade Peptide Injections Anti Aging CJC 1295 With DAC CAS 863288 34 0 Pharma Grade Peptide Injections Anti Aging CJC 1295 With DAC CAS 863288 34 0

Large Image :  Pharma Grade Peptide Injections Anti Aging CJC 1295 With DAC CAS 863288 34 0

Product Details:

Brand Name: RedBird

Payment & Shipping Terms:

Minimum Order Quantity: 10Vials
Price: Negotiated
Packaging Details: Disguise Package
Delivery Time: 3-7days after received payment
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 5000Vials Per Month
Detailed Product Description
Product Name: CJC-1295 With DAC Purity: 99%
Cas: 863288-34-0 Appearance: White Lyophilized Powder
Grade: Pharmaceutical Grade Usage: Anti Aging Peptide
High Light:

steroid based hormones

,

human growth peptides

Pharma Grade Peptide Injections Anti Aging CJC 1295 With DAC CAS 863288 34 0

 

Product Description

Alias: CJC-1295 Acetate; CJC1295(Without DAC);
Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-VAL-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Maleimidopropionyl)-NH2
Item: CJC1295
Synonyms: Mod GRF 1-29, CJC-1295 no DAC,CJC-1295 without DAC, CJC 1295 w/o DAC
CAS No.: 863288-34-0
Molecular Formula: C165H271N47O46
Molecular Weight: 3649.30
Purity (HPLC): 98.0%
Appearance: White crystalline powder
Single Impurity(HPLC): 1.0%
mino Acid Composition: 10% of theoretical
Peptide Content(N%): 80%(by %N)
Water Content(Karl Fischer): 6.0%
Acetate Content(HPIC): 15.0%
Identity (ESI-MS):3367.97±3.0
Mass Balance: 95.0~105.0%
Type: Immune Function AgentsGrade
Standard: Medicine Grade

CJC 1295 without DAC is a 30 amino acid peptide hormone, better known in the community as a GHRH. Essentially, what this means is this peptide will release a series of pulses over a long period of time which usually equates to fewer injections. Even though CJC 1295's main function upon creation was found to boost protein synthesis, increased growth of muscle tissue and many other benefits come with it as well. CJC 1295 also helps injury recovery times, reduce body fat, boost immune system and bone density and cellular repair (skin and organs). To clear up many misconceptions, let's get the semantics out of the way from the beginning. CJC 1295 without DAC is not CJC-1295, but is misnamed Mod GRF. When a peptide doesn't include DAC it's really not CJC 1295 but commonly called so. Confusing right? Here is a visual of MOD GRF (CJC 1295 no DAC).

Pharma Grade Peptide Injections Anti Aging CJC 1295 With DAC CAS 863288 34 0 0

 

Description:

CJC-1295 is a derivative of human GH-releasing factor1-29(HGRF1-29). HGRF1-29 is a naturally occurring peptide that is actually a truncated form of a larger peptide that binds to the growth hormone secretagogue receptor (GHS-R) and causes the release of growth hormone. CJC-1295 has four amino acids substituted in its chain that result in strong binding to serum albumin and prolong its half-life in the body.

 

Because of the way CJC-1295 is engineered its half life has been extended from ~7 minutes to greater than 7 days!. This is convenient as it means the product only needs to be injected 1-2 times per week for continuously elevated levels of Human Growth Hormone (HGH) and IGF-1. A single subcutaneous (sc) injection results in measurable quantities of CJC-1295 in the blood for up to 13 days. Additionally, a single dose of 60 ug/kg of CJC-1295 results in elevated levels of growth hormone (125%) while the pulsatile secretion of GH is maintained. Furthermore, 60 ug/kg of CJC-1295 elevated IGF-1 levels to the upper limit of normal. A dose of 30 ug/kg of CJC-1295 given weekly maintained its response with no evidence of desensitization.

The advantage of using CJC-1295 instead of actual HGH injections is that injecting HGH shuts down the body's own natural production and therefore when injections are ceased, the body’s ability to produce it's own HGH may be impaired and take some time to recover. Since CJC-1295 only stimulates the body's own HGH production, this risk is not apparent.

Another very positive benefit of CJC-1295/CJC-1293 is its ability to promote slow wave sleep. Slow wave sleep is also known as deep sleep and is the portion of sleep responsible for the highest level of muscle growth and memory retention. SWS are decreased significantly in older adults and also with people who tend to exercise later in the evening. This peptide has a benefit to side effect ratio that exceeds all others currently being legally sold and would make a great addition to ones training regimen or post cycle therapy.

Clinical Research was first conducted for CJC-1295 during the mid-2000s. The objective of the peptide was to treat visceral fat deposits in obese AIDS patients, as increased levels of exogenous hgH are presumed to increase lipolysis (fat loss). The clinical research was ultimately successful for most research subjects.

 

Applications:

 

Those looking for anti-aging benefits, improved physique and sense of well being.

Administration of single doses of CJC-1295 resulted in a 2- to 10-fold increase in mean serum GH levels in all dosing groups, which was dose incremental and persisted for up to 6 days. Similarly, a dose-related increase in mean serum IGF-I levels was observed at all dose levels, ranging from 1.5- to 3-fold and persisting for up to 14 days. Administration of ascending multiple doses of CJC-1295 resulted in elevated levels of GH, similar to those observed after a single dose.

 

In contrast, elevations in IGF-I levels showed a progressive effect over time, particularly in subjects receiving CJC-1295 every 7 d. Results of the multiple-dose study suggest both a cumulative pharmacokinetic effect [i.e. persistence of elevated predose levels of IGF-I in all dosing groups except group 1 (i.e. two injections of 30 µg/kg)] and a pituitary priming effect (i.e.progressively greater Cmax and progressively shorter Tmaxafter serial dosing). The data indicate that a minimum dosing interval of 7 d appears reasonable. The most appropriate dosing interval will be determined based on actual efficacy and safety data from longer-term therapeutic studies in patients with various clinical conditions.

No serious adverse reactions were reported in either study. The most frequently reported adverse events in subjects receivingCJC-1295 were injection site reactions, consisting of transient pain, swelling, and induration that were sometimes accompanied by local urticaria. Injection site reactions tended to be more severe and/or prolonged at higher dose levels. Headache, diarrhea, and flushing were also observed, with occasional transient and mild hypotension, but occurred primarily at higher doses.

Adverse effects complicate the use of GH in the treatment of HIV-associated metabolic conditions such as wasting and lipodystrophy. Although increases in the daily dose of GH from 1 to 6 mg are associated with dose-responsive benefits, doses of 2–3 mg/d or greater are associated with edema, arthralgias, and glucose intolerance. These side effects can become dose limiting. In the current studies, none of the subjects experienced these adverse effects. Future clinical trials on this disorder will confirm whether the use of GHRH rather than GH will circumvent these problems, as has been suggested in recent publications.

 

In summary, a single sc administration of CJC-1295 produced sustained elevations of serum GH and IGF-I levels in normal subjects for nearly 2 wk. Weekly or biweekly administration of CJC-1295 resulted in stimulation of GH and IGF-I secretion for at least 7 d. Both single and multiple doses of CJC-1295 over 2 wk were safe and generally well tolerated, particularly at doses of 30 and 60 µg/kg. Future studies are indicated to evaluate the clinical utility of treatment with CJC-1295 in patients with intact GH secretory capacity.

 

Now for any GH releaser’s benefits to reach full potential, somatostatin has to be controlled because it will inhibit gh release. Using an agent known as an Acetylcholinesterase inhibitor will allow acetyl chlorine levels to rise by preventing acethylcholineesterase from overriding acetylcholine; acetylcholine will inhibit somastostatin production. An example of a natural acetylcholinieestarase would be Huzperine A. A recommended dosage for HuzperineA would be around 50mcg. Now as mentioned before a more potent pharm grade somastostatin inhibitor would be Ipamorelin.

 

Logically speaking it would make PERFECT sense to combine CJC-1295 with Ipamorelin since you get the increase in GH from CJC and the increase of GH pulse frequencies with a reduction in somatostatin from the Ipamorelin. This leads to a maximal GH release effect, thus allowing for maximum anabolism from optimized GH without desensitization.

 

 

Dosages and Usage:

 

The naming might have thrown you for a loop, but don’t let that stop you from understanding the reason why you should utilize one of the best GHRH’s out there. CJC 1295 is probably the best and most widely use GHRH along with your chosen GHRP. Like all of the other peptides you are dealing with, it is a delicate lyophilized powder that should be kept out of the light and in a cool dry place. Reconstitution is done with bacteriostatic water or sodium chloride meant for injection. As already stated before, to mimic the natural release of growth through the natural spikes you would achieve through the day MOD GRF 1-29 (CJC 1295 without DAC) should be injected 1-3 times per day at 100mcg-200mcg doses along with your GHRP of choice. Now, the most cost effective and in my opinion better way to utilize CJC 1295 is to go with the CJC 1295 with DAC. This will allow the bodybuilder or athlete to inject 2mg of CJC 1295 with DAC twice weekly along with their daily injection of GHRP. This will offer smaller but more frequent growth pulses that would ideally get a user closer to exogenous HGH doses.

 

Result:


In conclusion, CJC 1295 with DAC is a powerful growth releasing that can be effectively used with a GHRP in order to maximize the greatest endogenous growth release bodybuilders and athletes are looking for. Even though CJC 1295 with DAC may be a bit more expensive than MOD GRF 1-29 (CJC 1295 without DAC), it is still the preferred and more powerful GHRH component in your peptide protocol.

 

Related Products:

 

1 Abarelix Acetate 98% 183552-38-7
2 Alarelin Acetate 98% 79561-22-1
3 Angiotensin Acetate 98% 58-49-1
4 Angiotensin II 98% 68521-88-0
5 Antide Acetate 98% 112568-12-4
6 Argpressin Acetate 98% 113-79-1
7 Argreline Acetate 98% 616204-22-9
8 Atosiban Acetate 98% 90779-69-4
9 Aviptadil Acetate 98% 40077-57-4
10 Bate-Amyloid(1-42)human 95% 107761-42-2
11 Bivalirudin Trifluoroacetate 98% 128270-60-0
12 Buserelin acetate 98% 57982-77-1
13 Calcuitonin   9007/12/9
14 Carbetocin Acetate 98% 37025-55-1
15 Carperitide 98% 89213-87-6
16 Cerropin B 98%  
17 Cetrorelix Acetate 98% 130143-01-0
18 Cetrorelix Acetate 98% 130143-01-0
19 CJC-1295 98% 863288-34-0
20 Copper Peptide(GHK-Cu) 98% 49557-75-7
21 CRF (human, rat) Acetate 98% 86784-80-7
22 CRF (ovine) Trifluoroacetate 98% 79804-71-0
23 Deslorelin Acetate 98% 57773-65-6
24 Desmopressin Acetate 98% 16679-58-6
25 Dynorphin A (1-13) Acetate 98% 72957-38-1
26 Elcatonin Acetate 98% 60731-46-6
27 Eledoisin Acetate 98% 69-25-0
28 Endothelin-1 Acetate 98% 117399-94-7
29 Enfuvirtide Acetate (T-20) 95% 159519-65-0
30 Eptifibatide Acetate 98% 148031-34-9/188627-80-7
31 Exenatide Acetate 98% 141732-76-5
32 Felypressin Acetate 98% 56-59-7
33 Fertirelin Acetate 98% 38234-21-8
34 Ganirelix acetate 98% 123246-29-7
35 GHRP-2 Acetate 98% 158861-67-7
36 GHRP-6 Acetate 98% 87616-84-0
37 Glatiramer Acetate 99% 147245-92-9
38 GLP(7-36) 98% 107444-51-9
39 GLP-1 (7-37) Acetate 98% 106612-94-6
40 Glucagon Hydrochloride 98% 16941-32-5
41 Gonadorelin Acetate 98% 34973-08-5
42 Goserelin Acetate 98% 145781-92-6
43 GRF (human) Acetate 98% 83930-13-6
44 Hexarelin Acetate 98% 140703-51-1
45 Histrelin Acetate 98% 76712-82-8
46 Icatibant Acetate 98% 30308-48-4
47 Lanreotide 98% 108736-35-2

Contact Details
WuHan RedBird Biotech Co,Ltd.

Contact Person: tommy

Send your inquiry directly to us (0 / 3000)